Blog

Feb 03, 2024

China laparoscopic trocars market poised to reach $30 million by 2030, forecasts GlobalData

Being home to the largest elderly population in the world, China has a high prevalence of metabolic and chronic diseases. Elderly patients remain physically and emotionally vulnerable to surgical

Being home to the largest elderly population in the world, China has a high prevalence of metabolic and chronic diseases. Elderly patients remain physically and emotionally vulnerable to surgical treatments and operations to treat such medical conditions. Laparoscopy is one of the most preferred minimally invasive techniques that improve surgical outcomes in the elderly population. As a result, the domestic laparoscopic instruments market will continue to grow at a compound annual growth rate of 4% through 2030, forecasts GlobalData, a leading data, and analytics company.

GlobalData’s report, “China Laparoscopic Access Instruments Market Size (Value, Volume, ASP) by Segments, and Forecast, 2015-2030,” reveals that China will account for about 29% of the Asia-Pacific (APAC) laparoscopic devices market in 2023.

Ayshi Ganguly, Medical Devices Analyst at GlobalData, comments: “Invasive surgeries make elderly people more susceptible to complications than the youth. Moreover, they are expensive, take longer recovery times, and pose infection risks post surgeries. This calls for the need for laparoscopic access instruments that can conduct minimally invasive surgeries and reduce complication rates for elderly patients.”

Laparoscopic access instruments such as trocars are designed to fit through smaller incisions and provide high-definition visuals and magnification, allowing doctors to perform complex surgeries with precision. Additionally, minimally invasive techniques cause lesser tissue damage and reduce postoperative pain and complications such as infection and bleeding. Further, such surgeries shorten hospital stays, which further reduces healthcare-associated costs and enables faster recovery for elderly patients.

Currently, the trocars market is dominated by auto-locking trocars and autosuture locking trocars marketed by WickiMed Huizhou Medical Equipment Manufacturing Co., Ltd. and Covidien LLC, respectively. Recently, China’s National Medical Products Administration (NMPA) granted approval for marketing ArtiSential, developed by LivsMed, in China.

ArtiSential, a laparoscopic trocar that mimics a surgeon’s wrist and fingers, allows access to narrow surgical sites, facilitates 360° of freedom of movement, and gives the surgeon a realistic sense of the laparoscopic surgery for improved surgical precision and outcomes.

Ganguly concludes: “Surgeries with laparoscopic access instruments are scoring better than the invasive surgeries as they lower overall complication rates for elderly patients. The introduction of such devices will allow Chinese surgeons to have easier access to an improved tool for enhanced patient care and may soon replace invasive surgeries. It is also expected to encourage domestic companies to invest in similar technologies that can potentially boost the overall laparoscopic access instruments market in China.”

If you are a member of the press or media and require any further information, please get in touch, as we're very happy to help.